Reuters logo
BRIEF-Juniper Pharmaceuticals reports third quarter results
November 2, 2017 / 8:16 PM / a month ago

BRIEF-Juniper Pharmaceuticals reports third quarter results

Nov 2 (Reuters) - Juniper Pharmaceuticals Inc

* Juniper Pharmaceuticals reports third quarter 2017 financial and operating results

* Q3 loss per share $0.13

* Q3 revenue rose 12 percent to $13 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below